Two molecular networks merging — Zermatt collaboration and shared discovery
Collaborate

Collaborate to Advance
Rare Disease Therapeutics

We partner with academic labs, biotechs, and patient foundations to accelerate mechanism-driven discovery.

Submit a Proposal Who We Work With

Who We Work With

Four collaborator types — each with a distinct contribution to mechanism-driven discovery.

Academic labs

Partnering on mechanistic biology — shared hypotheses, cohort access, joint experiments.

Biotech companies

Joint target validation, modality-matched partnerships, shared go/no-go calls.

Patient foundations

Disease insight, natural history data, and community access — partnership rooted in patient outcomes.

Data collaborators

Multi-omics and cohort data sharing — secure infrastructure, IRB-aligned governance.

What Collaboration Looks Like

Common partnership shapes — most engagements blend several.

Submit Proposal

Tell us about your work

We review collaboration inquiries on a rolling basis and respond to relevant opportunities as promptly as possible.

Name